June 30, 2023
The U.S. Supreme Court on Friday told the Fourth and Eleventh circuits to revisit closely watched whistleblower cases targeting units of Allergan and Abbott Laboratories, teeing up tests of the high court's new ruling on the meaning of intentional fraud under the False Claims Act.
June 12, 2023
The U.S. Supreme Court's ruling that faulty yet reasonable compliance views can trigger False Claims Act liability is undermining defense bar positions in wide-ranging contexts, including a new circuit split over FCA cases involving kickbacks, according to the U.S. Department of Justice.
January 05, 2023
The never-not-busy False Claims Act realm will be extra active in 2023 as the U.S. Supreme Court delivers at least one FCA opinion — and perhaps two or even three — in headliner cases during a year in which attorneys are also eyeing a new circuit split and emerging enforcement frontiers.
January 03, 2023
While many Americans were bringing glad tidings and popping bubbly, attorneys spent the final week of 2022 bringing lawsuits, appeals and other court filings of eye-popping significance for health care providers and drug companies in cases involving the False Claims Act, the opioid crisis and purported price-fixing schemes.
January 02, 2023
The New Year will see the U.S. Supreme Court deciding limits on the government's ability to dismiss whistleblower False Claims Act cases, while circuit courts are expected to address the limits of procurement law. Here, Law360 looks at eight cases to watch in 2023 that have the potential to significantly impact government contractors.
October 24, 2022
False Claims Act cases targeting erroneous yet reasonable views of compliance duties have produced an acrimonious "muddle" in the nation's circuit courts, a whistleblowing former executive told the U.S. Supreme Court, which is already signaling interest in the law's disputed standards for intentional overbilling.